Loading…
Loading…
CNCR (Loncar Cancer Immunotherapy ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| OVLU | Invesco Russell 1000 Value Factor ETF | $30.09 | $7.2M |
| LVUS | Hartford Multifactor Low Volatility US Equity ETF | $28.55 | $7.1M |
| RWDC | Direxion MSCI Defensives Over Cyclicals ETF | $47.02 | $7.1M |
| OYLD | Invesco Russell 1000 Yield Factor ETF | $27.46 | $7.0M |
| NSCS | Nuveen Small Cap Select | $26.84 | $7.0M |
| BOB | Alpha Architect Merlyn.AI Best-of-Breed Core Momentum ETF | $19.93 | $6.9M |
| GBDV | Global Beta Smart Income ETF | $23.44 | $6.9M |
| SMDY | Syntax Stratified MidCap | $44.16 | $6.8M |
| JJM | iPath Series B Bloomberg Industrial Metals Subindex Total Return ETN | $56.50 | $6.8M |
| LSLT | Pacer Salt Low truBeta US Market ETF | $32.00 | $6.7M |